688553 汇宇制药
2023/09 - 九个月
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
2019/12
人民币(K¥)
经营活动产生之现金流量净额20,552194,060446,363387,948326,221
投资活动产生之现金流量净额311,618(181,034)(1,872,122)(226,086)(278,900)
筹资活动产生之现金流量净额236,446(99,990)2,347,248(49,291)165,830
汇率变动对现金及现金等价物的影响--(161)(42)(191)276
现金及现金等价物净增加/(减少)568,616(87,125)921,447112,380213,427
期初现金及现金等价物余额1,205,8451,292,970371,522259,14245,716
期末现金及现金等价物余额1,774,4601,205,8451,292,970371,522259,142